|
|
|
Insider
Information: |
Luo Mary Z. |
Relationship: |
COO,Chief Scientist & ... |
City: |
Rancho Cucamonga |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
2,433,554 |
|
Indirect Shares
|
8,057,435 |
|
|
Direct
Value |
$102,744,650 |
|
|
Indirect Value
|
$340,184,906 |
|
|
Total
Shares |
10,490,989 |
|
|
Total
Value |
$442,929,556 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amphastar Pharmaceuticals, Inc. |
AMPH |
COO,Chief Scientist & ... |
2024-03-17 |
2,433,554 |
2024-03-17 |
8,057,435 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
170 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2018-12-11 |
4 |
S |
$21.43 |
$1,433,150 |
I/I |
(66,757) |
7,394,837 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2018-12-12 |
4 |
S |
$21.21 |
$794,736 |
I/I |
(37,469) |
7,357,368 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2018-12-13 |
4 |
S |
$20.99 |
$623,166 |
I/I |
(29,689) |
7,327,679 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2018-12-14 |
4 |
S |
$20.48 |
$892,309 |
D/D |
(43,577) |
2,072,317 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2019-03-15 |
4 |
A |
$0.00 |
$0 |
I/I |
41,522 |
1,432,112 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2019-03-15 |
4 |
OE |
$15.84 |
$8,154,163 |
D/D |
514,783 |
2,587,100 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2019-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
98,368 |
2,224,371 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2019-03-15 |
4 |
D |
$20.23 |
$9,676,049 |
D/D |
(478,302) |
2,207,166 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2019-03-15 |
4 |
OE |
$15.84 |
$3,559,834 |
I/I |
224,737 |
1,591,443 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2019-03-15 |
4 |
D |
$20.23 |
$4,211,279 |
I/I |
(208,170) |
1,424,795 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2019-03-16 |
4 |
D |
$20.23 |
$239,361 |
I/I |
(11,832) |
1,412,963 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2019-03-16 |
4 |
D |
$20.23 |
$555,839 |
D/D |
(27,476) |
2,179,690 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2019-03-17 |
4 |
D |
$20.23 |
$654,926 |
D/D |
(32,374) |
2,147,316 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2019-03-17 |
4 |
D |
$20.23 |
$282,026 |
I/I |
(13,941) |
1,399,022 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2020-03-15 |
4 |
D |
$14.19 |
$385,670 |
D/D |
(27,179) |
2,120,137 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2020-03-15 |
4 |
D |
$14.19 |
$136,125 |
I/I |
(9,593) |
1,389,429 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2020-03-16 |
4 |
D |
$13.03 |
$337,125 |
D/D |
(25,873) |
2,094,264 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2020-03-16 |
4 |
A |
$0.00 |
$0 |
I/I |
68,303 |
1,449,961 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2020-03-16 |
4 |
D |
$13.03 |
$101,256 |
I/I |
(7,771) |
1,381,658 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2020-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
152,724 |
2,246,988 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, COB |
|
2021-03-15 |
4 |
D |
$19.15 |
$537,885 |
D/D |
(28,088) |
2,218,900 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, COB |
|
2021-03-15 |
4 |
D |
$19.15 |
$183,687 |
I/I |
(9,592) |
1,440,369 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2021-03-16 |
4 |
D |
$18.44 |
$465,444 |
D/D |
(25,241) |
2,193,659 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2021-03-16 |
4 |
D |
$18.44 |
$163,932 |
I/I |
(8,890) |
1,431,479 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2021-03-17 |
4 |
A |
$0.00 |
$0 |
I/I |
56,892 |
1,488,371 |
0 |
- |
|
170 Records found
|
|
Page 5 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|